World's Best Scientists 2026 revealed!
Cecil Czerkinsky

Cecil Czerkinsky

D-Index & Metrics

Immunology

D-Index
64
Citations
16970
World Ranking
2916
National Ranking
124

Cecil Czerkinsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cecil Czerkinsky sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 191 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cecil Czerkinsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cecil Czerkinsky sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cecil Czerkinsky is affiliated with Université Côte d'Azur in France and specializes in medicine, with a focus on infectious diseases. Their research emphasizes the SARS-CoV-2 virus and COVID-19, including clinical studies, vaccine coverage, and hesitancy.

The scientist's frequent publication venues include the SSRN Electronic Journal, EBioMedicine, Clinical Infectious Diseases, The Lancet, and bioRxiv (Cold Spring Harbor Laboratory).

Key research topics covered in their work are:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • COVID-19 Impact on Reproduction
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Influenza Virus Research Studies
  • Virus-based gene therapy research

Frequent co-authors collaborating with Cecil Czerkinsky include:

  • Emanuela Martinuzzi
  • Paul Hofman
  • Nicolas Glaichenhaus
  • A Sicard
  • Jonathan Benzaquen

Representative recent papers include:

  • Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients (2021, EBioMedicine)
  • Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients (2021, SSRN Electronic Journal)
  • A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects (2022, Clinical Infectious Diseases)
  • COVID-19 vaccination and HIV-1 acquisition (2022, The Lancet)
  • A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients (2021, bioRxiv [Cold Spring Harbor Laboratory])

Cecil Czerkinsky has contributed to book publications, with a notable title including:

  • Impact of Microbiome on Gut Mucosal Immunity in Health and Disease (2022, Frontiers Media)

Best Publications

  • Mucosal immunity and vaccines

    Jan Holmgren;Cecil Czerkinsky

  • A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

    Cecil C. Czerkinsky;Lars-Åke Nilsson;Håkan Nygren;Örjan Ouchterlony

  • Evidence for several waves of global transmission in the seventh cholera pandemic

    Ankur Mutreja;Dong Wook Kim;Dong Wook Kim;Nicholas R Thomson;Thomas R Connor

  • Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.

    Cecil Czerkinsky;Gudrun Andersson;Hans-Peter Ekre;Lars-Åke Nilsson

  • Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems

    Jan Holmgren;Nils Lycke;Cecil Czerkinsky

  • Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

    Jia-Bin Sun;Jan Holmgren;Cecil Czerkinsky

  • Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges.

    Jan Holmgren;Cecil Czerkinsky;Kristina Eriksson;Ali Mharandi

  • IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans

    Cecil Czerkinsky;Shirley J. Prince;Suzanne M. Michalek;Susan Jackson

  • Mucosal immunity and tolerance: relevance to vaccine development

    Cecil Czerkinsky;Fabienne Anjueie;Jerry R. McGhee;Annie Geoige-Chundy

  • Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

    C Czerkinsky;M W Russell;N Lycke;M Lindblad

  • Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.

    M Quiding-Järbrink;I Nordström;G Granström;A Kilander

  • A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

    Isabelle Bergerot;Corinne Ploix;Jacob Petersen;Valerie Moulin

  • Mucosal Immunity: Implications for Vaccine Development

    Jan Holmgren;Cecil Czerkinsky;Nils Lycke;Ann-Mari Svennerholm

  • Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

    M Quiding;I Nordström;A Kilander;G Andersson

  • Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.

    Cecil Czerkinsky;William J. Koopman;Susan Jackson;Jennifer E. Collins

  • Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

    Jan Holmgren;Jenni Adamsson;Fabienne Anjuère;John Clemens

  • A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.

    Cecil Czerkinsky;Cecil Czerkinsky;Zina Moldoveanu;Jiri Mestecky;Lars-Åke Nilsson

  • Sublingual vaccination with influenza virus protects mice against lethal viral infection

    Joo Hye Song;Huan H. Nguyen;Nicolas Cuburu;Nicolas Cuburu;Taisuke Horimoto

  • Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.

    Nicolas Çuburu;Mi-Na Kweon;Joo-Hye Song;Catherine Hervouet

  • Buccal and sublingual vaccine delivery

    Heleen Kraan;Hilde Vrieling;Cecil Czerkinsky;Wim Jiskoot

  • Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

    Jia-Bin Sun;Carola Rask;Tomas Olsson;Jan Holmgren

Frequent Co-Authors

Jan Holmgren
Jan Holmgren University of Gothenburg
Dong-Wook Kim
Dong-Wook Kim Ewha Womans University
Jiri Mestecky
Jiri Mestecky University of Alabama at Birmingham
Jehee Lee
Jehee Lee Jeju National University
Zina Moldoveanu
Zina Moldoveanu University of Alabama at Birmingham
Jongsik Chun
Jongsik Chun Seoul National University
John D. Clemens
John D. Clemens University of California, Los Angeles
Eugene C. Butcher
Eugene C. Butcher Stanford University
Michael W. Russell
Michael W. Russell University at Buffalo, State University of New York
Mi-Na Kweon
Mi-Na Kweon University of Ulsan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many professionals pivot from clinical roles into specialized fields, often through expedited education options. Programs like accelerated RN to NP programs enable registered nurses to advance rapidly into nurse practitioner roles, which can complement immunology expertise in patient care.

Transitioning from family-focused nursing roles to acute care nursing practitioners is another popular pathway. The FNP to ACNP bridge program online offers flexibility for nurses to deepen their clinical skills relevant to immunological disorders.

For individuals without a nursing background aiming to enter healthcare, online accelerated nursing programs for non nurses provide a fast track into the profession. These programs can be foundational before specializing in immunology-related advanced practice roles.

Considering financial goals is also essential. Salaries for advanced practitioners vary significantly depending on location. Reviewing DNP salary by state can guide candidates toward regions with the best compensation aligned with their career ambitions.

Best Scientists Citing Cecil Czerkinsky

Trending Scientists

Recently Published Articles